Before you respond with WTF?
(What’s this foolishness?), please take a moment to consider this: the potential therapeutic use of nicotine has been an ongoing question for medical research since 1926.
Nicotine’s use in treating neurodegenerative conditions like Alzheimer’s disease, Parkinson’s disease and mild cognitive impairment, as well as neuropsychiatric conditions like ADHD, schizophrenia, autism, depression, Down syndrome, and chemobrain, has been investigated for years. The research just hasn’t received much attention in the medical community.
You are invited to spend an evening with one of the world’s leading experts on the clinical use of nicotine to educate yourself about a potential new tool for your therapeutic toolkit.
Our guide for the evening will be Dr. Paul A. Newhouse, director of the Center for Cognitive Medicine in the department of psychiatry at Vanderbilt University Medical Center. He is also Jim Turner professor of cognitive disorders at Vanderbilt’s school of medicine and professor of psychiatry, pharmacology and medicine.
World No Tobacco Day is May 31, a day dedicated to raising awareness of the dangers of smoking. Please join us a few days before that to consider the benefits of nicotine and the risks of throwing out the baby with the bathwater.
The District 11 Doctors’ Lounge Program is part of the district’s health and wellness initiative designed to provide Toronto physicians with opportunities to interact in a collegial, non-clinical setting.
The OMA facilitates the distribution of communications for its various constituency groups, and therefore the views and the opinions expressed in this communication may not reflect the views, policies, and opinions of the OMA. The OMA does not warrant the accuracy, timeliness, or completeness of the information contained in this communication, nor does it accept any responsibility for its contents.